FDO Partners’s Allergan plc AGN Stock Holding History

FDO Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-18,966	Closed	-$4.61M	–	319
2017 Q2	$4.61M	Buy	+18,966	New	+$4.46M	0.99%	16
2016 Q1	–	Sell	-2,704	Closed	-$845K	–	355
2015 Q4	$845K	Buy	+2,704	New	+$805K	0.48%	87

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

FDO Partners's AGN Position: Q3 2017 in Review

FDO Partners sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 18,966 shares — an estimated $4.61M sold.

FDO Partners first reported a position in AGN in Q4 2015 and held it in 2 quarters. The position peaked at $4.61M in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

FDO Partners reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
FDO Partners sold 18,966 Allergan plc shares in Q3 2017, an estimated $4.61M.
FDO Partners first reported a position in Allergan plc in Q4 2015 and held it in 2 quarters.
FDO Partners's Allergan plc position peaked at $4.61M in Q2 2017.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on FDO Partners's 13F filing for Q3 2017, filed 13 Nov 2017.